Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Blood Simpling AB
AB
In liquidation
Org 5594302068
Falun
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 2023 · 3 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
Blood Simpling AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
0
Staff expenses
−8
EBITDA
−99
Depreciation & amort.
—
EBIT
−99
Net financials
−16
Profit before tax
Balance sheet
SEK thousands
Item
2024
Total assets
207
Equity
−59
Long-term debt
263
Short-term debt
3
Total debt
266
Financial ratios
5-year trend
EBITDA margin
-9865100.0%
This company
15.8%
Market median
-62437442% vs market
2024
2024
Equity ratio
-28.7%
This company
38.2%
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-04-14 – 2024-08-31
View
PDF
More on Blood Simpling AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
−114
Tax
—
Net profit
−114
Market median
-175% vs market
2024
2024
Return on equity
-11427100.0%
This company
18.4%
Market median
-62103904% vs market
2024
2024
Net profit margin
-11427100.0%
This company
8.1%
Market median
-141075409% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
4.49×
This company
0.62×
Market median
-624% vs market
2024
2024
